bosentan anhydrous has been researched along with Adjuvant Arthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuer, R; Gajda, M; Glück, L; Imhof, AK; Schaible, HG; Schulz, S | 1 |
| Bombonato-Prado, KF; Cunha, FQ; Cunha, TM; Donadi, EA; Donate, PB; Ferreira, SH; Junta, CM; Lima, FO; Louzada, P; Passos, GA; Peres, RS; Verri, WA; Vieira, SM | 1 |
| D'Orléans-Juste, P; De-Melo, JD; Rae, GA; Tonussi, CR | 1 |
3 other study(ies) available for bosentan anhydrous and Adjuvant Arthritis
| Article | Year |
|---|---|
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Bosentan; Disease Models, Animal; Edema; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Nociception; Phenylpropionates; Pyridazines; Secondary Prevention; Sulfonamides | 2011 |
Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.
Topics: Adult; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Bosentan; Cells, Cultured; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Female; Gene Expression Profiling; Humans; Leukocytes, Mononuclear; Lymph Nodes; Male; Methotrexate; Mice; Mice, Inbred DBA; Middle Aged; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sulfonamides | 2012 |
Effects of endothelin-1 on inflammatory incapacitation of the rat knee joint.
Topics: Animals; Arthritis, Experimental; Bosentan; Carrageenan; Endothelin Receptor Antagonists; Endothelin-1; Endotoxins; Hindlimb; Hyperalgesia; Joints; Lipopolysaccharides; Male; Rats; Rats, Wistar; Sulfonamides; Vasoconstrictor Agents; Viper Venoms | 1998 |